Endoscopic ultrasound-guided fiducial marker placement for image-guided radiation therapy without fluoroscopy: safety and technical feasibility

Background and study aims: Endoscopic ultrasound (EUS)-guided fiducial marker placement for image-guided radiation treatment (IGRT) is becoming more widespread. Most case series report the procedure performed using fluoroscopy for spatial geometry although the benefits of this are unclear. The aim of our study is to report the technical feasibility, safety, and migration rate of fiducial marker placement in a large cohort of patients with gastrointestinal malignancies who underwent EUS-guided fiducial marker placement for IGRT without fluoroscopy.

Patients and methods: A retrospective chart review was performed on all patients referred for EUS-guided fiducial marker placement from 08/1/07 to 7/31/14 at Moffitt Cancer Center.

Results: During the study period, 514 patients underwent placement of 1093 gold fiducial markers under EUS-guidance. Two hundred and forty patients with esophageal/gastro-esophageal junction cancer had 405 fiducials placed. In 188 patients with pancreatic ancer, 510 fiducials were placed. In 54 patients with rectal cancer, 103 fiducials were placed and 32 patients had 75 fiducials placed into other gastrointestinal tract lesions. Minor bleeding, which resolved spontaneously, occurred in two patients. Technical difficulty in placing fiducials was noted in 18 patients. Intraprocedural fiducial migration was noted in two patients and only 2/1093 fiducials (.002%) in two esophageal patients migrated as noted on simulation computed tomography scan.

Conclusions: EUS-guided fiducial marker placement without fluoroscopy is technically feasible and safe. There were minimal intraprocedure/post-procedure complications. Imaging at the time of simulation also revealed the migration rate to be extremely low. These results may allow for more widespread adoption of EUS-guided fiducial marker placement.

• References

• 1 Chang BW, Saif MW. Stereotactic body radiation therapy (SBRT) in pancreatic cancer: is it ready for prime time?. JOP 2008; 9: 676-682
• 2 Kothary N, Dieterich S, Louie JD et al. Percutaneous implantation of fiducial markers for imaging-guided radiation therapy. AJR Am J Roentgenol 2009; 192: 1090-1096
• 3 Jun-Ho Choi, Dong-Wan Seo, Do Hyun Park et al. Fiducial placement for stereotactic body radiation therapy under only endoscopic ultrasonography guidance in pancreatic and hepatic malignancy: practical feasibility and safety. Gut Liver 2014; 8: 88-93
• 4 Ammar T, Coté GA, Creach KM et al. Fiducial placement for stereotactic radiation by using EUS: feasibility when using a marker compatible with a standard 22-gauge needle. Gastrointest Endosc 2010; 71: 630-633
• 5 Varadarajulu S, Trevino JM, Shen S et al. The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a case series. Endoscopy 2010; 42: 423-425
• 6 Fernandez DC, Hoffe SE, Barthel JS et al. Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy. Pract Radiat Oncol 2013; 3: 32-39
• 7 Park WG, Yan BM, Schellenberg D et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc 2010; 71: 513-518
• 8 Sanders MK, Moser AJ, Khalid A et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc 2010; 71: 1178-1184
• 9 Pishvaian AC, Collins B, Gagnon G et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006; 64: 412-417
• 10 Yang J, Abdel-Wahab M, Ribeiro A. EUS-guided fiducial placement after radical prostatectomy before targeted radiation therapy for prostate cancer recurrence. Gastrointest Endosc 2011; 73: 1302-1305
• 11 Chandran S, Vaughan R, Efthymiou M et al. A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer. Endosc Int Open 2014; 2 E153-159
• 12 Machiels M, Hooft Jv, Jin P et al. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers. Gastrointest Endosc 2015; 82: 641-649
• 13 Ghassemi S, Faigel DO. EUS-guided placement of fiducial markers using a 22-gauge needle. [Abstract] Gastrointest Endosc 2009; 69: AB337-AB338
• 14 DiMaio 1 CJ, Nagula S, Goodman KA et al. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle. Gastrointest Endosc 2010; 71: 1204-1210
• 15 Owens DJ, Savides TJ. EUS placement of metal fiducials by using a backloaded technique with bone wax seal. Gastrointest Endosc 2009; 69: 972-973
• 16 Khashab MA, Kim KJ, Tryggestad EJ et al. Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. Gastrointest Endosc 2012; 76: 962-971
• 17 Moningi S, Walker AJ, Malayeri AA et al. Analysis of fiducials implanted during EUS for patients with localized rectal cancer receiving high-dose rate endorectal brachytherapy. Gastrointest Endosc 2015; 81: 765-769
• 18 Majumder S, Berzin TM, Mahadevan A et al. Endoscopic Ultrasound-Guided Pancreatic Fiducial Placement- How Important is Ideal Fiducial Geometry?. Pancreas 2013; 42: 692-695
• 19 Shridhar R, Chuong MD, Weber J et al. Preoperative Dose Painting IMRT Chemoradiation to 56 Gy in Esophageal Cancer Doubles Pathologic Complete Response Rate without Increasing Toxicity. ASTRO 2012; 84: S42 (http://dx.doi.org/10.1016/j.ijrobp.2012.07.320)
• 20 Mellon EA, Hoffe SE, Springett GM et al. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiation therapy for borderline resectable and locally advanced pancreatic cancer. Acta Oncol 2015; 1-7
• 21 Gao SJ, Qiao X, Wu F et al. Pathological Analysis of Clinical Target Volume Margin for Radiotherapy in Patients with Esophageal and Gastroesophageal junction cancer Int. J. Radiation Oncology Biol. Phys 2007; 67: 389-396
• 22 Bouchard M, McAleer MF, Starkchall G. Impact of Gastric Filling on Radiation Dose Delivered to Gastroesophageal junctions tumors. J. Radiation Oncology Biol. Phys 2010; 77: 292-300
• 23 Fernandez DC, Hoffe SE, Barthel JS et al. Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy. Pract Radiat Oncol 2013; 3: 32-39